RDY Operating Cash Flow (Statement)

Dr. Reddy's Laboratories Ltd Common Stock · Operating Cash Flow (Statement)

RDY logo

RDY Operating Cash Flow (Statement)

Latest reported₹40.99B INR
RDY TTM Cash from Operations · INR (₹5.28B → ₹40.99B)
High-resolution chart · PNG

RDY operating cash flow (statement) history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (INR)
Period endingOperating Cash Flow (Statement) (INR)
40,991,807,000
56,547,807,000
63,106,000,000
58,818,000,000
52,561,000,000
46,428,000,000
24,568,192,064
18,001,346,360
26,611,346,360
29,365,346,360
48,906,154,296
72,113,000,000
63,468,000,000
58,873,000,000
48,315,000,000
42,386,000,000
38,211,000,000
28,108,000,000
19,142,426,220
1,869,881,527
6,017,881,527
20,378,881,527
20,254,744,983
27,552,289,676
28,404,289,676
27,324,289,676
34,006,000,000
42,937,000,000
43,559,000,000
28,704,000,000
27,774,000,000
19,007,000,000
14,986,000,000
18,029,000,000
20,765,000,000
18,478,000,000
14,480,000,000
21,513,000,000
22,252,000,000
29,018,000,000
37,693,000,000
41,247,000,000
42,252,000,000
36,012,000,000
29,083,000,000
25,033,000,000
22,860,000,000
23,151,000,000
19,532,000,000
19,463,000,000
13,951,000,000
11,428,000,000
13,919,000,000
13,317,000,000
17,578,000,000
19,114,000,000
17,125,000,000
16,150,000,000
10,138,000,000
9,052,000,000
10,063,000,000
8,009,000,000
8,988,000,000
7,397,000,000
9,769,000,000
13,226,000,000
16,605,000,000
13,741,474,000
7,900,445,000
4,505,000,000
2,222,155,164
3,681,697,709
4,863,067,702
6,122,639,998
8,570,072,672
11,301,734,962
14,770,029,135
11,832,504,516
6,641,031,643
3,756,735,150
686,831,017
1,647,402,249
3,224,642,026
2,525,768,245
2,304,869,974
2,291,615,599
1,684,695,767
2,495,465,314
3,363,001,610
4,007,896,067
3,742,634,687
3,645,368,554
3,341,783,093
4,354,171,080
5,280,821,860
6,382,635,564
6,036,109,499
4,647,679,666
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.